That's not because we're getting such better care. Right. It's because our processes are so inefficient. Right. It's harder to get generic drugs and generic drug devices to market. You know, it's, it's, I've got a bill to address that on drug devices, prices for certain services, administrative costs. (28:58–29:03)
CLAIM
Asserts that it is difficult to get generic drugs and devices to market in the US.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
